References
- Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 2017;197:S142-S145
- Babjuk M, Bohle A, Burger M, Capoun O, Cohen D, Comperat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 2017;71:447-461
- Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, et al. Bladder cancer, version 5.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2017;15:1240-1267
- Donin NM, Lenis AT, Holden S, Drakaki A, Pantuck A, Belldegrun A, et al. Immunotherapy for the treatment of urothelial carcinoma. J Urol 2017;197:14-22
- Leibovici D, Zisman A, Chen-Levyi Z, Cypele H, Siegel YI, Faitelovich S, et al. Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin. J Urol 2000;164:1546-1549
- Alexander RB, Mann DL, Borkowski AA, Fernandez-Vina M, Klyushnenkova EN, Kodak J, et al. Granulomatous prostatitis linked to HLA-DRB1*1501. J Urol 2004;171:2326-2329
- Lamm DL, van der Meijden PM, Morales A, Brosman SA, Catalona WJ, Herr HW, et al. Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600
- Stillwell TJ, Engen DE, Farrow GM. The clinical spectrum of granulomatous prostatitis: a report of 200 cases. J Urol 1987;138:320-323
- Butel R, Ball R. The distribution of BCG prostatitis: a clue for pathogenetic processes? Prostate 2018;78:1134-1139
- LaFontaine PD, Middleman BR, Graham SD Jr, Sanders WH. Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy. Urology 1997;49:363-366
- Garcia Solano J, Sanchez Sanchez C, Montalban Romero S, Perez-Guillermo M. Diagnostic dilemmas in the interpretation of fine-needle aspirates of granulomatous prostatitis. Diagn Cytopathol 1998;18:215-221
- Uzoh CC, Uff JS, Okeke AA. Granulomatous prostatitis. BJU Int 2007;99:510-512
- Beltrami P, Ruggera L, Cazzoletti L, Schiavone D, Zattoni F. Are prostate biopsies mandatory in patients with prostate-specific antigen increase during intravesical immunoor chemotherapy for superficial bladder cancer? Prostate 2008;68:1241-1247
- Gottlieb J, Princenthal R, Cohen MI. Multi-parametric MRI findings of granulomatous prostatitis developing after intravesical bacillus calmette-guerin therapy. Abdom Radiol (NY) 2017;42:1963-1967
- Kim CY, Lee SW, Choi SH, Son SH, Jung JH, Lee CH, et al. Granulomatous prostatitis after intravesical Bacillus Calmette-Guerin instillation therapy: a potential cause of incidental F-18 FDG uptake in the prostate gland on F-18 FDG PET/CT in patients with bladder cancer. Nucl Med Mol Imaging 2016;50:31-37
- Bour L, Schull A, Delongchamps NB, Beuvon F, Muradyan N, Legmann P, et al. Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess. Diagn Interv Imaging 2013;94:84-90
- Ma W, Kang SK, Hricak H, Gerst SR, Zhang J. Imaging appearance of granulomatous disease after intravesical Bacille Calmette-Guerin (BCG) treatment of bladder carcinoma. AJR Am J Roentgenol 2009;192:1494-1500
- Suzuki T, Takeuchi M, Naiki T, Kawai N, Kohri K, Hara M, et al. MRI findings of granulomatous prostatitis developing after intravesical Bacillus Calmette-Guerin therapy. Clin Radiol 2013;68:595-599
- Dianat SS, Matoso A, Carter BH, Macura KJ. Multiparametric MRI findings of granulomatous prostatitis after intravesical bacillus Calmette-Guerin therapy in a patient undergoing active surveillance. Clin Genitourin Cancer 2014;12:e215-e219
- Diaz de Leon A, Costa DN, Francis F, Pedrosa I. Case 258: granulomatous prostatitis. Radiology 2018;289:267-271
- Uysal A, Karaosmanog˘ lu AD, Karcaaltincaba M, Akata D, Akdogan B, Baydar DE, et al. Prostatitis, the great mimicker of prostate cancer: can we differentiate them quantitatively with multiparametric MRI? AJR Am J Roentgenol 2020;215:1104-1112
- Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2. Eur Urol 2019;76:340-351